Akums Drugs intimated exchanges about availability of audio recording for its Q4 FY26 and full-year FY26 results conference call held on May 18, 2026.
The company will share the transcript of the call with exchanges and upload it to its investor relations website in due course.
Disclosure made pursuant to SEBI Listing Regulations regarding investor/analyst communication following financial results announcement.